Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. The company was formerly known as Avalon GloboCare Corp. and changed its name to Change Agents Corporation in July 2026. Change Agents Corporation was founded in 2015 and is headquartered in Freehold, New Jersey.…
Change Agents Joins Meta's Muse Developer Program to Expand Distribution of its AI-Powered Applications, Catch-Up and Beacon
Change Agents (NASDAQ: CHGA) is listed on Nasdaq, where its shares trade in USD. It belongs to the Real Estate Services industry, part of the Real Estate sector, and reports about 2 employees.
The shares were at 0.7101 USD on 20 November 2026, down 98.2% over 52 weeks. Its 52-week range is 0.6931 USD to 41.60 USD: the price is 98.3% below the high and 2.5% above the low.
Its market capitalisation is 1.17M USD.
Change Agents reports return on equity of -197.8%.
Its debt exceeds its cash by 1.97M USD, a debt-to-equity ratio of 0.10. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.
No upcoming events tracked.